Live weekly webinars for innovation, R&D and IP professionals
PatSnap answers the hardest questions encountered throughout the innovation life cycle—from creating new inventions to commercialising them.
The tool stores in one place all the information typically consulted by R&D and intellectual property teams—including millions of patents, scientific journals, litigation data, as well as company technology and financial profiles.
Our deep learning algorithms find patterns across these billions of data points, so you get game-changing insights in the blink of an eye.
Get your free demonstration today: www.patsnap.com/contact
Scientists in the biotech and pharma industries spend a large amount of time and resources on researching sequences. However, often as researches progress to the later stages of R&D, they become blocked by competitors and products that are already on the market.
Using a sequence searching tool which links to patent data can help you identify obstacles and freedom to operate much earlier on. Having access to a full data set sooner, can help you save time, money and enhance your R&D.
Join this webinar to find out how you can accelerate FTO searches on your sequences.
Technology commercialisation at its core requires for an invention to be applied to a use case in a specific market. Doing this successfully will ensure that you are getting ROI out of your research and inventions. Mireya McKee has over 16 years experience in research, academia and commercialisation and will be talking about how she utilises technology trends to maximise commercialisation value.
Some of the topics discussed in this webinar will be:
* How to track technology trends
* What can patents tell us about technology trends
* Technology adoption cycle
* How technology readiness levels can affect commercialisation opportunities
Patent licensing negotiations have an extremely high fail rate- this can be down to unfavourable licensing terms or weak patent portfolios. One of the ways universities and industry are trying to bridge the gap between innovation and commercialisation is by working together much earlier.
From a university standpoint, their research can be tailored to specific industry needs, as well as having research costs covered. Through the eyes of industry, they can get their hands on the latest research developments, and attract the brightest and talented individuals to their businesses.
Laura Schoppe, President and Founder of Fuentek, who has years experience helping TTO's improve their chances of commercalisation will be joining us to discuss:
- How to start sourcing strategic sponsorship deals
- Where to begin with searching and conversations for partnerships
- The benefits of this chosen pathway. i.e Minimising risk
Please note: All viewers will have their data shared with our guest speaker.
A ‘Patent cliff’ describes a severe drop in revenue once the patent for a company’s leading product expires. The sharp revenue decline is a result of competitors being able to start developing and selling the product, often at a much lower price.
As US biopharmaceutical company Celgene struggles to get regulatory approval from the FDA, the company is facing major market, shares and revenue losses, and is facing a phenomenal patent cliff. Furthermore, research from EvaluatePharma reports that an estimated $250 billion in projected sales is at risk between 2018-2024 as many drugs lose exclusivity.
When it comes to acquisitions, the effects of a dwindling patent term can severely impact the value of your company. So how do you create 5-year plan to prepare for an inevitable patent cliff? We are very excited to welcome back Jurgen Vollrath, President of Exponential Technology Counsel, and customer of PatSnap. ET Counsel, advise clients on IP strategy & business alignment to ensure the most successful M&A and exit outcomes.
In this webinar, Jurgen will be discussing:
- Risk vs. reality when it comes to patent cliffs
- How to create a 5-year M&A plan for your organisation
- How to find potential acquisition targets
- Predicting the potential impact a patent cliff could have on your business.
Social Impact Investment brings together capital and experience from the public, private and non-for-profit industries to achieve specific social objectives. The return of these investments is measured typically by the social outcomes achieved.
The Centre of Advancing Innovation is a public-private partnership non-profit focused on identifying breakthrough inventions hidden in portfolios, to maximise investor returns and commercial success. Research performed by the group has highlighted that Social Impact projects accelerate innovation, and result in higher returns.
In this webinar, Rosemarie Truman, CEO and Founder of CAI will be discussing the positive implications of choosing social impact projects for your business, including:
- Why they accelerate innovation
- How these projects can increase your potential investment opportunities for the future
- The influence on the future funding of projects.
With innovation budgets increasing each year and R&D becoming more competitive, many organisations are getting creative in how they increase the reach of their IP protection.
One technique is to widen IP claims by patenting human experiences induced by the product or service. This is often seen in the automotive and consumer goods sectors, commonly describing visual and tactile sensations around the original technology.
Jason Lye, IAM 300 Strategist & Founder of Lyco Works has worked with many clients using this technique and will be hosting this webinar to discuss how your company could benefit from broadening patent claims in this way. He will also cover:
- What patenting human experiences really means and looks like
- The importance of not forgetting the human-impact your technologies create
- How claim-broadening technique offers another layer of protection for your technology
- Why it will make it much harder for your competitors to trap you in litigation cases.
Mature products, such as smartphones and cars, tend to become very similar – whether they are from different manufacturers or the latest model from the same manufacturer.
Speed, power and slight changes in appearance become the focus for many companies. Marketing can make advances through insightful methods to dig deeper into opportunities from unmet needs – but the right science and technology are required to make them real.
R&D teams have access to incredible developments in science and technology, such as artificial intelligence and the latest developments in genetics, but struggle to find how to link them with market opportunities. Opportunities become ‘market pull’ or ‘technology push’, without joining together. Innovation opportunities must connect customer needs with science and technology to be more than just ideas or technologies.
This webinar will demonstrate how technology mapping can be used to discover new opportunities, whichever direction you start from, and how IP landscapes can then help you to make the right connections.
Please note: Registrants details will be shared with the presenter after the webinar.
In an age where technology and cars have never been more intertwined, experts believe the most successful automotive companies in the future, are the leaders in the smart manufacturing race today. A recent survey of automotive companies by Capgemini’s Digital Transformation Institute revealed that 49% of automotive companies have invested over $250mn in smart factory innovation.
The ability to integrate currently siloed systems throughout manufacturing processes with smart techniques is clearly beneficial, and of course, it isn’t just about software and connectivity tools, it's about making better business decisions by using data to solve problems before they happen.
But how can you begin making your organisation smarter? PatSnap is pleased to welcome Paul Mairl, Chief Digital Officer at GKN Powder Metallurgy. Paul has worked within GKN for over 25 years and is now responsible for setting up GKN Powder Metallurgy's digital system in line with Industry 4.0.
In this webinar, Paul will be sharing:
- What smart manufacturing really means
- How GKN successfully integrated it across their shop floor
- Techniques you can use to successfully integrate smart manufacturing processes into your organisation
- The benefits and barriers of these techniques
In a recent survey by Harvard Business Review, it was revealed that on average, only 23% of participants said they learned about a competitors innovation early enough to respond before it hit the market. Whilst competition is inevitable, there are strategies you can implement to decrease the risk they pose to your business.
Join our upcoming webinar, hosted by Christopher Ralph as we explore how to successfully track the activities of your competitors using patent data. Other themes covered in this webinar include:
• Identifying emerging players in your market
• The benefits of keeping, or bringing your competitor tracking back in-house
• Communicating competitor intelligence to colleagues
• Competitors as opportunities, not just threats.
Modern drug discovery appears in many ways to be well-defined with tried-and-tested approaches to acquire success. However, some research processes often lead to very few new discoveries and sometimes stagnation of an entire research area.
So, does it always have to be this way? One method to re-boot a failing area of research is to employ disruptive chemical methods and thinking to kick-start a process of rejuvenation.
We invite you to our webinar with Roshan Jumnah, Chemical IP data analyst at PatSnap to explore:
- Can we identify the reasons why drug discovery is failing?
- Chemical disruption, its uses, and the impact of this new approach on the pharmaceutical industry
- The ways chemical disruption can reverse failing drug discovery in the future.